XML 26 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
Jun. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 5,952,143 $ 17,350,116
Short-term investments 13,487,062 12,863,420
Accounts receivable 432,108 467,909
Accounts receivable from affiliated entity 33,446 38,406
Prepaid expenses and other current assets 598,482 746,049
Prepaid expenses and other current assets from affiliated entity 813,935 441,186
Total current assets 21,317,176 31,907,086
Restricted cash 100,234 100,059
Fixed assets, net 421,519 295,785
Intangible assets, net 8,393,119 9,310,485
Goodwill 10,113,371 10,113,371
Investment in affiliated entity 7,517,596 9,071,513
Investment in common stock warrants 509,800 100,000
Other assets 223,056 208,262
Total assets 48,595,871 61,106,561
Current liabilities:    
Accounts payable and accrued expenses 3,522,672 4,318,942
Accounts payable and accrued expenses due to affiliated entity 53,613 20,344
Accrued clinical trial expenses 1,160,643 1,059,372
Common stock warrants 5,038,510 5,176,319
Deferred revenue 41,864 79,502
Deferred revenue from affiliated entity 413,542 388,542
Total current liabilities 10,230,844 11,043,021
Deferred revenue, net of current portion 77,643 80,450
Deferred revenue from affiliated entity, net of current portion 1,774,194 1,961,694
Deferred rent 75,224 80,875
Deferred tax liabilities 78,859 78,859
Total liabilities 12,236,764 13,244,899
Inovio Pharmaceuticals, Inc. stockholders' equity:    
Common stock 134,968 134,968
Additional paid-in capital 258,113,218 257,235,707
Accumulated deficit (222,479,302) (210,091,174)
Accumulated other comprehensive income 64,514 35,393
Total Inovio Pharmaceuticals, Inc. stockholders' equity 35,833,398 47,314,894
Non-controlling interest 525,709 546,768
Total stockholders' equity 36,359,107 47,861,662
Total liabilities and stockholders' equity $ 48,595,871 $ 61,106,561